Full Name | Ban Allos |
---|---|
Gender | Female |
Speciality | Infectious Disease |
Experience | 39 Years |
Location | 3601 Tvc, Nashville, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457435562 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | MD20780 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Vanderbilt University Medical Center | Nashville, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Vanderbilt University Medical Center | 5092023416 | 2711 |
News Archive
EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for CepleneĀ® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.
Funding cuts and austerity measures are damaging young people's access to mental health services, with potentially long-term consequences for their mental wellbeing, say researchers at the University of Cambridge.
A new study finds African American women derive similar breast cancer risk reductions associated with multiple births and breastfeeding as white women, but that recent trends may lead to a rising risk.
The Robert Wood Johnson Foundation (RWJF) today announced its selection of Lynne Holden, M.D., co-founder and president of Mentoring in Medicine in New York City, to receive a Community Health Leaders Award.
Inc. magazine ranked Signature Genomic Laboratories no. 1012 on its third annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The company, which performs microarray-based diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, experienced three-year sales growth of 302.9%, more than twice that of the Inc. 5000 industry median and over 12 times the industry benchmark. Signature was also ranked 70th of companies in the healthcare sector.
› Verified 4 days ago
Entity Name | Vanderbilt University Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104202761 PECOS PAC ID: 5092023416 Enrollment ID: O20151006000369 |
News Archive
EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for CepleneĀ® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.
Funding cuts and austerity measures are damaging young people's access to mental health services, with potentially long-term consequences for their mental wellbeing, say researchers at the University of Cambridge.
A new study finds African American women derive similar breast cancer risk reductions associated with multiple births and breastfeeding as white women, but that recent trends may lead to a rising risk.
The Robert Wood Johnson Foundation (RWJF) today announced its selection of Lynne Holden, M.D., co-founder and president of Mentoring in Medicine in New York City, to receive a Community Health Leaders Award.
Inc. magazine ranked Signature Genomic Laboratories no. 1012 on its third annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The company, which performs microarray-based diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, experienced three-year sales growth of 302.9%, more than twice that of the Inc. 5000 industry median and over 12 times the industry benchmark. Signature was also ranked 70th of companies in the healthcare sector.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Ban Allos, MD 3841 Green Hills Village Dr Ste 200, Nashville, TN 37215-2691 Ph: (615) 322-3000 | Ban Allos, MD 3601 Tvc, Nashville, TN 37232-0001 Ph: (615) 322-3000 |
News Archive
EpiCept Corporation announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for CepleneĀ® (histamine dihydrochloride). EpiCept is seeking approval for Ceplene, administered concomitantly with low-dose interleukin-2 (IL-2), for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first complete remission.
Funding cuts and austerity measures are damaging young people's access to mental health services, with potentially long-term consequences for their mental wellbeing, say researchers at the University of Cambridge.
A new study finds African American women derive similar breast cancer risk reductions associated with multiple births and breastfeeding as white women, but that recent trends may lead to a rising risk.
The Robert Wood Johnson Foundation (RWJF) today announced its selection of Lynne Holden, M.D., co-founder and president of Mentoring in Medicine in New York City, to receive a Community Health Leaders Award.
Inc. magazine ranked Signature Genomic Laboratories no. 1012 on its third annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The company, which performs microarray-based diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, experienced three-year sales growth of 302.9%, more than twice that of the Inc. 5000 industry median and over 12 times the industry benchmark. Signature was also ranked 70th of companies in the healthcare sector.
› Verified 4 days ago
Megan Desai, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Pike, Nashville, TN 37205 Phone: 615-222-6726 Fax: 615-222-3702 | |
Harrison Klause, Infectious Disease Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
John N Bowers, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike Ste 500, Nashville, TN 37205 Phone: 629-255-2493 Fax: 629-255-4266 | |
Dr. Evan Zehr, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1161 21st Ave S, Nashville, TN 37232 Phone: 615-322-6943 | |
Spurthi N Bhatt, MD MPH Infectious Disease Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Mr. Robert M Johnson, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2410 Patterson St, Suite 106, Nashville, TN 37203 Phone: 615-340-4611 Fax: 615-340-4658 | |
Mr. John E Anderson, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St, Suite 400, Nashville, TN 37203 Phone: 615-342-5900 Fax: 615-342-5912 |